OCT, a leading contract research organization in the Russian Federation and Easterm Europe, has announced the appointment of Anastasia Shtro as Head of Business Development. In this role, Anastasia will be responsible for developing and implementing the company’s growth strategy, expanding partnerships, and identifying new opportunities for growth.
Anastasia has over 20 years of experience in the pharmaceutical industry, specializing in project management and business development. Prior to joining OCT, Anastasia held leadership positions at companies such as Oximio, STADA and Nizhpharm.
“We are delighted to welcome Anastasia to our team. We are confident that her extensive experience in the international market and her deep industry knowledge will enable OCT to reach new heights,” commented Dmitry Sharov, CEO of OCT.
“I am enthusiastic to join the team and ready to contribute to the company’s continued development. My key goals include expanding the company’s presence in the local and Asian markets, as well as developing and implementing effective strategies that will allow OCT to strengthen its position and achieve outstanding results,” added Anastasia.